Does treatment of cadaveric organ donors with desmopressin increase the likelihood of pancreas graft thrombosis? results of a preliminary study

Desmopressin (DDAVP) is commonly used in cadaveric organ donors to treat diabetes insipidus. The thrombogenic potential of DDAVP is well known. Recent animal data have demonstrated that DDAVP impairs pancreas graft (PG) microcirculation and perfusion. The aim of this study was too evaluate the effec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation proceedings 2004-05, Vol.36 (4), p.1048-1049
Hauptverfasser:	Marques, R.G, Rogers, J, Chavin, K.D, Baliga, P.K, Lin, A, Emovon, O, Afzal, F, Baillie, G.M, Taber, D.J, Ashcraft, E.E, Rajagopalan, P.R
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Cadaver Clinical death. Palliative care. Organ gift and preservation Deamino Arginine Vasopressin - adverse effects Deamino Arginine Vasopressin - pharmacology Female Follow-Up Studies Humans Male Medical sciences Pancreas - drug effects Pancreas Transplantation - adverse effects Pancreas Transplantation - physiology Postoperative Complications - epidemiology Retrospective Studies Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Thrombosis - epidemiology Time Factors Tissue Donors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!